|  Help  |  About  |  Contact Us

Publication : miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.

First Author  Wang H Year  2010
Journal  Brain Res Volume  1357
Pages  166-74 PubMed ID  20709030
Mgi Jnum  J:165149 Mgi Id  MGI:4836328
Doi  10.1016/j.brainres.2010.08.023 Citation  Wang H, et al. (2010) miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res 1357:166-74
abstractText  MicroRNAs (miRNAs) are abundantly expressed in the brain and play an important role in disorders of the brain, including Alzheimer's diseases (AD). Growing body of evidence suggests that the TGF-beta signaling pathway plays a key role in the pathogenesis of AD. However, it is unclear whether miRNAs involved in AD pathogenesis by regulating TGF-beta signaling. Here we found that miR-106b and TGF-beta type II receptor (TbetaR II) were aberrantly expressed in APPswe/PSE9 mice (a double transgenic mouse model for AD). Sequence analysis revealed two putative binding sites for miR-106b in the 3' UTR of the TbetaR II mRNA. Our results showed that the expression of miR-106b was inversely correlated with TbetaR II protein levels and miR-106b can directly inhibit the TbetaR II translation in vitro. After induced neurodifferentiation with all-trans retinoic acid, we observed significant neurodegeneration in SH-SY5Y cells stably transfected with miR-106b. Western blot analysis revealed unchanged total Smad2/3 protein levels, but reduced phospho-Smad2/3 (p-Smad2/3) and increased Smad6/7 protein levels in the miR-106b stably transfected cell line. Exposure of SH-SY5Y cells to Abeta42 oligomers led to the expression of miR-106b was first increased and then decreased and TbetaR II levels reduced. Our in vitro results suggested that Abeta42 oligomer-induced miR-106b leads to impairment in TGF-beta signaling through TbetaR II, concomitant with retinoic acid-induced neurodegeneration in SH-SY5Y cells. These results show that TbetaR II is a functional target of miR-106b and that miR-106b may influence TGF-beta signaling, thereby contributing to the pathogenesis of AD.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression